Literature DB >> 24158106

Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.

Luc Laberge1, Jean Mathieu, Julie Auclair, Éric Gagnon, Luc Noreau, Cynthia Gagnon.   

Abstract

AIMS: To identify sociodemographic, clinical, and central correlates of health-related quality of life (HRQoL) in DM1 patients.
METHODS: 200 DM1 patients had assessments of muscular impairment, CTG repeats, and intelligence. Validated instruments were used to assess sociodemographic and clinical factors as well as social support, social participation, daytime sleepiness, fatigue, personality, mood, and quality of life. Regression analysis was used to identify correlates of SF-36 physical and mental component summary scores.
RESULTS: Patients scored lower on all SF-36 physical health subscales compared with normative data but did not differ with respect to mental health function. Regression analysis revealed that psychological distress, fatigue, severe muscular impairment, emotional stability, not having worked within the last 12 months, and lower intellectual quotient were associated with lower scores in physical health function. Moreover, neuroticism, daytime sleepiness, dissatisfaction with social participation, and lower conscientiousness were associated with lower scores in mental health function.
CONCLUSION: DM1 has an impact on SF-36 physical summary scores but not on mental summary scores. Factors such as fatigue, daytime sleepiness, psychological distress, unemployment, and social participation dissatisfaction that significantly affect HRQoL in DM1 are amenable to treatment and psychosocial interventions, namely by providing care that integrate health, social, and community services.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24158106     DOI: 10.1159/000353991

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  16 in total

1.  Measuring quality of life in muscular dystrophy.

Authors:  Carla M Bann; Richard T Abresch; Barbara Biesecker; Kristin Caspers Conway; Chad Heatwole; Holly Peay; Peter Scal; Jonathan Strober; Karen Uzark; Jodi Wolff; Marjorie Margolis; Angela Blackwell; Natalie Street; Angela Montesanti; Julie Bolen
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

2.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

3.  A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Émilie Petitclerc; Marie Kierkegaard; Jean Mathieu; Élise Duchesne; Luc J Hébert
Journal:  J Neurol       Date:  2018-05-21       Impact factor: 4.849

4.  Subjective-objective sleepiness discrepancy in adult-onset myotonic dystrophy type 1.

Authors:  Sasikanth Gorantla; Gregory Blume; Madeleine Grigg-Damberger
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

Review 5.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

6.  Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.

Authors:  Luc Laberge; Benjamin Gallais; Julie Auclair; Yves Dauvilliers; Jean Mathieu; Cynthia Gagnon
Journal:  J Neurol       Date:  2019-10-31       Impact factor: 4.849

7.  Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.

Authors:  Sigrid Baldanzi; Paolo Cecchi; Serena Fabbri; Ilaria Pesaresi; Costanza Simoncini; Corrado Angelini; Ubaldo Bonuccelli; Mirco Cosottini; Gabriele Siciliano
Journal:  Neuroimage Clin       Date:  2016-06-15       Impact factor: 4.881

Review 8.  A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Authors:  Lisa Minier; Baptiste Lignier; Cyrille Bouvet; Benjamin Gallais; Nathalie Camart
Journal:  J Neuromuscul Dis       Date:  2018

9.  Swallow-related quality of life and oropharyngeal dysphagia in myotonic dystrophy.

Authors:  Walmari Pilz; Valéria Lima Passos; Rob J Verdonschot; Jolanda Meijers; Nel Roodenburg; Yana Halmans; Catharina G Faber; Bernd Kremer; Laura W J Baijens
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-15       Impact factor: 2.503

10.  Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Authors:  Garazi Labayru; Irati Arenzana; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga A
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.